PMC:7214327 / 1499-4004
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 286-296 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T3 | 402-405 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T4 | 416-419 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T5 | 494-497 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T6 | 752-762 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T7 | 780-783 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T8 | 903-913 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T9 | 955-958 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T10 | 974-985 | Body_part | denotes | nucleotides | http://purl.org/sig/ont/fma/fma82740 |
T11 | 1754-1757 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T12 | 1825-1831 | Body_part | denotes | serine | http://purl.org/sig/ont/fma/fma82764 |
T13 | 2001-2004 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T14 | 2374-2377 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T15 | 2501-2504 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T8 | 118-123 | Disease | denotes | Ebola | http://purl.obolibrary.org/obo/MONDO_0005737 |
T9 | 243-247 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 600-608 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 613-621 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T12 | 1262-1270 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T13 | 1275-1283 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T14 | 2222-2230 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T15 | 2299-2307 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T16 | 2343-2351 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 52-53 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 83-91 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T10 | 105-112 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T11 | 170-175 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T12 | 197-198 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T13 | 284-285 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T14 | 375-376 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T15 | 455-458 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T16 | 511-512 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T17 | 639-642 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T18 | 810-813 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T19 | 867-868 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T20 | 1081-1084 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T21 | 1197-1204 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T22 | 1360-1363 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T23 | 1462-1463 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T24 | 1534-1535 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T25 | 1678-1679 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T26 | 1782-1785 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T27 | 1956-1957 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T28 | 2070-2077 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T29 | 2166-2167 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T30 | 2234-2236 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T31 | 2309-2315 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2. (A) |
T32 | 2423-2424 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T13 | 13-18 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T14 | 22-32 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T15 | 286-296 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T16 | 319-331 | Chemical | denotes | triphosphate | http://purl.obolibrary.org/obo/CHEBI_18036 |
T17 | 355-357 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T18 | 666-668 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T19 | 692-714 | Chemical | denotes | Adenosine triphosphate | http://purl.obolibrary.org/obo/CHEBI_15422 |
T20 | 692-701 | Chemical | denotes | Adenosine | http://purl.obolibrary.org/obo/CHEBI_16335 |
T21 | 702-714 | Chemical | denotes | triphosphate | http://purl.obolibrary.org/obo/CHEBI_18036 |
T22 | 716-719 | Chemical | denotes | ATP | http://purl.obolibrary.org/obo/CHEBI_15422|http://purl.obolibrary.org/obo/CHEBI_30616 |
T24 | 721-729 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T25 | 752-762 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T26 | 836-850 | Chemical | denotes | hydroxyl group | http://purl.obolibrary.org/obo/CHEBI_43176 |
T27 | 836-844 | Chemical | denotes | hydroxyl | http://purl.obolibrary.org/obo/CHEBI_29191 |
T28 | 845-850 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T29 | 858-860 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T30 | 903-913 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T31 | 974-985 | Chemical | denotes | nucleotides | http://purl.obolibrary.org/obo/CHEBI_36976 |
T32 | 1043-1045 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T33 | 1527-1529 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T34 | 1825-1839 | Chemical | denotes | serine residue | http://purl.obolibrary.org/obo/CHEBI_32848 |
T35 | 1825-1831 | Chemical | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
T36 | 2143-2145 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 494-507 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T5 | 498-507 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T6 | 780-793 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T7 | 784-793 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T8 | 936-945 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
T9 | 955-968 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T10 | 959-968 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T11 | 1754-1767 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T12 | 1758-1767 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T13 | 2001-2014 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T14 | 2005-2014 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T15 | 2374-2387 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T16 | 2378-2387 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T17 | 2482-2491 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T16 | 0-269 | Sentence | denotes | One of these drugs is remdesivir (RDV), which shows a broad spectrum of anti-viral activity against many viruses like Ebola (4,5), Nipah (6, 7, 8), respiratory syncytial virus (RSV) family (8) and a diverse category of coronaviruses including SARS CoV and MERS CoV (9). |
T17 | 270-635 | Sentence | denotes | Remdesivir is a nucleotide analogue (4), and the triphosphate form of RDV, i.e., RDV-TP is being used as a substrate for many viral RNA-dependent RNA polymerase (RdRp) complexes and it has been reported to inhibit the viral RNA synthesis by a specific mechanism of delayed chain termination for all three coronaviruses (MERS-CoV, SARS-CoV and SARS-CoV-2) RdRp (10). |
T18 | 636-806 | Sentence | denotes | It has been observed that RDV-TP resembles specifically Adenosine triphosphate (ATP) molecule and competes with the nucleotide during the viral RNA synthesis (Figure 1 ). |
T19 | 807-1067 | Sentence | denotes | It has been reported that 3′ hydroxyl group of RDV-TP forms a phosphodiester bond with the next nucleotide but it terminates the formation of viral RNA synthesis at 3 nucleotides downstream, precisely at i + 3 position, whereas the RDV-TP is the i-th position. |
T20 | 1068-1342 | Sentence | denotes | Moreover, it has also been fascinating to note that the underlying mechanism of chain termination is more or less common in many viruses including all the recent coronaviruses, namely MERS-CoV, SARS-CoV and SARS-CoV-2, though the precise molecular mechanism remains elusive. |
T21 | 1343-1563 | Sentence | denotes | Additionally, it has been reported very recently that the main reason of chain termination at i + 4 position is due to a steric clash between 1′-CN substituent of the incorporated RDV-TP and a specific residue S861 (10). |
T22 | 1564-1768 | Sentence | denotes | It is consistent with the chain termination at i + 3 position due to the imposed inability of RdRp to translocate a single position downstream, so eventually it terminates the nascent viral RNA synthesis. |
T23 | 1769-1874 | Sentence | denotes | Moreover, it has also been imperative to note that this serine residue is conserved in all coronaviruses. |
T24 | 1875-2015 | Sentence | denotes | Though, the actual molecular mechanism is still not very clear but this could be a plausible explanation of termination viral RNA synthesis. |
T25 | 2016-2238 | Sentence | denotes | Recently, scientists also expressed RdRp of different viruses and measure kinetic parameters to infer its interaction with RDV-TP and also determined a score of 0.77 mmol half maximal concentration against SARS-CoV-2 (11). |
T26 | 2239-2505 | Sentence | denotes | Figure 1 Probable molecular mechanism of Remdisivir against SARS-CoV- 2. (A) Thematic diagram shows the SARS-CoV-2 viral entry and its RNA synthesis which can be block by Remdisivir. (B) Detail molecular mechanism of Remdisivir to inhibit the synthesis of viral RNA. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
31 | 2299-2310 | Species | denotes | SARS-CoV- 2 | Tax:2697049 |
32 | 2343-2353 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
33 | 2280-2290 | Chemical | denotes | Remdisivir | |
34 | 2410-2420 | Chemical | denotes | Remdisivir | |
35 | 2456-2466 | Chemical | denotes | Remdisivir | |
69 | 432-436 | Gene | denotes | RdRp | Gene:43740578 |
70 | 625-629 | Gene | denotes | RdRp | Gene:43740578 |
71 | 1658-1662 | Gene | denotes | RdRp | Gene:43740578 |
72 | 2052-2056 | Gene | denotes | RdRp | Gene:43740578 |
73 | 118-123 | Species | denotes | Ebola | Tax:1570291 |
74 | 148-175 | Species | denotes | respiratory syncytial virus | Tax:12814 |
75 | 219-232 | Species | denotes | coronaviruses | Tax:11118 |
76 | 243-251 | Species | denotes | SARS CoV | Tax:694009 |
77 | 256-264 | Species | denotes | MERS CoV | Tax:1335626 |
78 | 575-588 | Species | denotes | coronaviruses | Tax:11118 |
79 | 590-598 | Species | denotes | MERS-CoV | Tax:1335626 |
80 | 600-608 | Species | denotes | SARS-CoV | Tax:694009 |
81 | 613-623 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
82 | 1230-1243 | Species | denotes | coronaviruses | Tax:11118 |
83 | 1252-1260 | Species | denotes | MERS-CoV | Tax:1335626 |
84 | 1262-1270 | Species | denotes | SARS-CoV | Tax:694009 |
85 | 1275-1285 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
86 | 1860-1873 | Species | denotes | coronaviruses | Tax:11118 |
87 | 2222-2232 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
88 | 177-180 | Species | denotes | RSV | Tax:12814 |
89 | 22-32 | Chemical | denotes | remdesivir | MESH:C000606551 |
90 | 34-37 | Chemical | denotes | RDV | MESH:C000606551 |
91 | 270-280 | Chemical | denotes | Remdesivir | MESH:C000606551 |
92 | 340-343 | Chemical | denotes | RDV | MESH:C000606551 |
93 | 351-354 | Chemical | denotes | RDV | MESH:C000606551 |
94 | 662-665 | Chemical | denotes | RDV | MESH:C000606551 |
95 | 692-701 | Chemical | denotes | Adenosine | MESH:D000241 |
96 | 716-719 | Chemical | denotes | ATP | MESH:D000255 |
97 | 854-857 | Chemical | denotes | RDV | MESH:C000606551 |
98 | 1039-1042 | Chemical | denotes | RDV | MESH:C000606551 |
99 | 1523-1526 | Chemical | denotes | RDV | MESH:C000606551 |
100 | 1825-1831 | Chemical | denotes | serine | MESH:D012694 |
101 | 2139-2142 | Chemical | denotes | RDV | MESH:C000606551 |